Neogen Corporation
General ticker "NEOG" information:
- Sector: Health Care
- Industry: Medical - Diagnostics & Research
- Capitalization: $1.6B (TTM average)
Neogen Corporation follows the US Stock Market performance with the rate: 47.2%.
Estimated limits based on current volatility of 1.7%: low 9.93$, high 10.27$
Factors to consider:
- Total employees count: 2974 (+2.0%) as of 2025
- US accounted for 50.3% of revenue in the fiscal year ended 2024-05-31
- Top business risk factors: Integration of 3M food safety, Geopolitical risks, Pandemic risks, Market competition, Economic downturns and volatility
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-05-31 to 2027-05-31
- 2025-05-31 to 2026-05-31 estimated range: [4.78$, 10.52$]
- 2026-05-31 to 2027-05-31 estimated range: [5.33$, 10.95$]
Financial Metrics affecting the NEOG estimates:
- Positive: with PPE of 18.7 at the end of fiscal year the price was low
- Positive: -5.34 < Operating profit margin, % of 1.05
- Negative: negative Net income
- Negative: negative Industry operating income (median)
- Negative: 0 < Inventory ratio change, % of 0.51
- Positive: -0.03 < Operating cash flow per share per price, % of 4.36
- Positive: 42.57 < Shareholder equity ratio, % of 60.14 <= 64.23
Short-term NEOG quotes
Long-term NEOG plot with estimates
Financial data
| YTD | 2023-05-31 | 2024-05-31 | 2025-05-31 |
|---|---|---|---|
| Operating Revenue | $822.45MM | $924.22MM | $894.66MM |
| Operating Expenses | $784.93MM | $865.56MM | $1,955.66MM |
| Operating Income | $37.52MM | $58.66MM | $-1,061.00MM |
| Non-Operating Income | $-59.56MM | $-72.97MM | $-72.11MM |
| Interest Expense | $55.96MM | $73.39MM | $71.62MM |
| R&D Expense | $26.04MM | $22.48MM | $21.09MM |
| Income(Loss) | $-22.04MM | $-14.30MM | $-1,133.11MM |
| Taxes | $0.83MM | $-4.88MM | $-41.07MM |
| Net Income(Loss)* | $-22.87MM | $-9.42MM | $-1,092.04MM |
| Stockholders Equity | $3,134.22MM | $3,144.14MM | $2,071.25MM |
| Inventory | $133.81MM | $189.27MM | $190.86MM |
| Assets | $4,554.43MM | $4,548.83MM | $3,443.84MM |
| Operating Cash Flow | $41.03MM | $35.26MM | $58.24MM |
| Capital expenditure | $65.76MM | $111.42MM | $104.59MM |
| Investing Cash Flow | $201.04MM | $-29.31MM | $-99.19MM |
| Financing Cash Flow | $-118.08MM | $1.92MM | $-1.60MM |
| Earnings Per Share** | $-0.12 | $-0.04 | $-5.03 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.